'New treatment' presentation slideshows

Assessing Outcomes and Safety

965 views • 75 slides

A Case Report

A Case Report. History. Chief Complaint : Chronic Lyme Disease (088.81) 55 year old white female presents with whole body pain and fatigue including: neck and back pain, headaches, chronic fatigue, depression.

814 views • 50 slides

Aids

679 views • 46 slides

Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Sep. 16, 2005

Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Sep. 16, 2005. Lilly Yue, Ph.D.* CDRH, FDA, Rockville MD 20850 * No official support or endorsement by the Food and Drug Administration of this presentation is intended or should be inferred. Acknowledgements.

708 views • 44 slides

Early stopping for phase II cancer studies: a likelihood approach

Early stopping for phase II cancer studies: a likelihood approach. Elizabeth Garrett-Mayer, PhD Associate Professor of Biostatistics The Hollings Cancer Center The Medical University of South Carolina garrettm@musc.edu. Motivation. Oncology Phase II studies Single arm

481 views • 36 slides

Physician Scientist ?????

Physician Scientist ?????. Immunology Research Center Shie -Liang, Edmond, Hsieh ??????? ??? ?? Dr.James B. Wyngaarden , Director of the National Institutes of Health (April 29,1982-July 31,1989). Sir Hans Sloane (1660-1753).

632 views • 34 slides

The Ethics of Cancer Research

The Ethics of Cancer Research. Laurie Lyckholm MD Virginia Commonwealth University Department of Internal Medicine Division of Hematology/Oncology. The Ethics of Cancer Research. Historical content Is there such a thing as informed consent?

444 views • 33 slides

The Ethics of Cancer Research

The Ethics of Cancer Research. Laurie Lyckholm MD Virginia Commonwealth University Department of Internal Medicine Division of Hematology/Oncology. The Ethics of Cancer Research. Historical content Is there such a thing as informed consent?

460 views • 33 slides

The Ethics of Cancer Research

The Ethics of Cancer Research. Laurie Lyckholm MD Virginia Commonwealth University Department of Internal Medicine Division of Hematology/Oncology. The Ethics of Cancer Research. Historical content Is there such a thing as informed consent?

642 views • 33 slides

In France

643 views • 32 slides

GCIG Prague 2010

568 views • 31 slides

Intervention Trials Principles of study design

Intervention Trials Principles of study design. James B. Spies M.D.MPH Professor of Radiology Georgetown University School of Medicine Washington D. C. Categories of Studies Users Guide to Medical Literature. Studies answer one of 4 types of questions: Therapy (efficacy)

786 views • 26 slides

Tuberculosis in North Dakota 2011

Tuberculosis in North Dakota 2011. Craig Steffens, MPH TB/HIV Surveillance Coordinator. 2011 ND TB Cases. 8 total active cases 5 pulmonary 2 were smear positive One with PZA resistant, though not M. bovis 3 extra-pulmonary 3 male, 5 female. U.S.-born and Foreign-born TB Cases.

411 views • 26 slides

Non-parametric data analysis

361 views • 25 slides

Buprenorphine: A Promising Pharmacotherapy for the Treatment of Opioid Dependence

Buprenorphine: A Promising Pharmacotherapy for the Treatment of Opioid Dependence . Laura Haynes and Larissa Williams. Overview . Heroin Leading treatment in the U.S.: Methadone Experimental treatment: Buprenorphine Naltrexone Combination Treatment: Buprenorphine and Naltrexone

444 views • 19 slides

381 views • 16 slides

Economic evaluation of health programmes

Economic evaluation of health programmes. Department of Epidemiology, Biostatistics and Occupational Health Class no. 20: More on dealing with uncertainty Nov 17, 2008. Plan of class. Net benefit framework Cost-effectiveness acceptability curves

341 views • 14 slides

Judgment and Decision Making

664 views • 14 slides

253 views • 8 slides

FOR-DMD: Recruitment and Retention Challenges

FOR-DMD: Recruitment and Retention Challenges. Addressing the Challenges Benefits vs risks of corticosteroids? Why invest so much to study a treatment of established (short term) benefit? Corticosteroids vs curative new treatment? Does FOR-DMD preclude participation in another study?

269 views • 7 slides